Table 2.
Study author | T1DM cases | Healthy control | P-HWE | MAF | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
FF | Ff | ff | F | f | FF | Ff | Ff | F | f | |||
FokI (rs2228570) | ||||||||||||
Ban et al. [33] | 50 | 52 | 6 | 152 | 64 | 82 | 138 | 30 | 302 | 198 | 0.01 | 0.396 |
Fassbender et al. [34] | 35 | 30 | 10 | 100 | 50 | 19 | 30 | 8 | 68 | 46 | 0.48 | 0.403 |
Gyorffy et al. [35] | 32 | 56 | 19 | 120 | 94 | 34 | 47 | 22 | 115 | 91 | 0.44 | 0.441 |
Turpeinen (Turku) et al. [36] | 50 | 150 | 74 | 250 | 298 | 102 | 414 | 292 | 618 | 998 | 0.01 | 0.617 |
Turpeinen (Tampere) et al. [36] | 7 | 28 | 20 | 42 | 68 | 61 | 226 | 170 | 348 | 566 | 0.29 | 0.619 |
Turpeinen (Oulu) et al. [36] | 37 | 114 | 98 | 188 | 310 | 93 | 360 | 342 | 546 | 1044 | 0.9 | 0.656 |
Audi (barcellona) et al. [37] | 69 | 68 | 18 | 206 | 104 | 105 | 142 | 28 | 352 | 198 | 0.04 | 0.36 |
Audi (navarra) et al. [37] | 35 | 45 | 6 | 115 | 57 | 41 | 53 | 22 | 135 | 97 | 0.51 | 0.418 |
San Pedro et al. [38] | 31 | 35 | 5 | 97 | 45 | 41 | 39 | 8 | 121 | 55 | 0.76 | 0.312 |
Zemunik et al. [39] | 42 | 63 | 29 | 147 | 121 | 73 | 136 | 23 | 282 | 182 | < 0.001 | 0.392 |
Capoluongo et al. [40] | 89 | 112 | 45 | 290 | 202 | 91 | 127 | 28 | 309 | 183 | 0.09 | 0.371 |
Lemos et al. [41] | 81 | 101 | 25 | 263 | 151 | 97 | 114 | 38 | 308 | 190 | 0.63 | 0.381 |
Israni et al. [42] | 142 | 79 | 15 | 363 | 109 | 116 | 76 | 5 | 308 | 86 | 0.06 | 0.218 |
Mory et al. [43] | 80 | 81 | 16 | 241 | 113 | 91 | 67 | 24 | 249 | 115 | 0.04 | 0.315 |
Panierakis et al. [15] | 50 | 43 | 7 | 143 | 57 | 64 | 31 | 1 | 159 | 33 | 0.18 | 0.171 |
Yavuz et al. [44] | 61 | 46 | 10 | 168 | 66 | 60 | 63 | 11 | 183 | 85 | 0.32 | 0.317 |
Yokota et al. [45] | 50 | 46 | 12 | 146 | 70 | 59 | 20 | 141 | 138 | 302 | < 0.001 | 0.686 |
Bonakdaran et al. [46] | 38 | 25 | 6 | 101 | 37 | 18 | 20 | 7 | 56 | 34 | 0.71 | 0.377 |
Sahin et al. [47] | 54 | 31 | 0 | 139 | 31 | 43 | 28 | 9 | 114 | 46 | 0.19 | 0.287 |
Mohammadnejad et al. [48] | 49 | 33 | 5 | 131 | 43 | 55 | 40 | 5 | 150 | 50 | 0.5 | 0.25 |
Vedralova et al. [49] | 38 | 60 | 18 | 136 | 96 | 25 | 76 | 12 | 126 | 100 | < 0.001 | 0.442 |
Greer et al. [50] | 21 | 21 | 8 | 63 | 37 | 28 | 22 | 5 | 78 | 32 | 0.82 | 0.29 |
Hamed et al. [51] | 24 | 92 | 16 | 140 | 124 | 8 | 28 | 4 | 44 | 36 | 0.008 | 0.45 |
Abd-Allah et al. [52] | 58 | 50 | 12 | 166 | 74 | 78 | 38 | 4 | 194 | 46 | 0.8 | 0.191 |
Kafoury et al. [53] | 23 | 21 | 16 | 67 | 53 | 41 | 12 | 7 | 94 | 26 | 0.001 | 0.216 |
Nasreen et al. [54] | 32 | 12 | 0 | 76 | 12 | 25 | 19 | 0 | 69 | 19 | 0.06 | 0.215 |
Mukhtar et al. [55] | 84 | 13 | 5 | 181 | 23 | 100 | 0 | 0 | 200 | 0 | < 0.001 | 0 |
Ali et al. [56] | 64 | 33 | 3 | 161 | 39 | 79 | 21 | 2 | 179 | 25 | 0.66 | 0.122 |
Rasoul et al. [57] | 178 | 30 | 45 | 386 | 120 | 146 | 67 | 1 | 359 | 69 | 0.02 | 0.161 |
Study author | T1DM cases | Healthy control | P-HWE | MAF | ||||||||
TT | Tt | tt | T | t | TT | Tt | tt | T | t | |||
TaqI (rs731236) | ||||||||||||
Chang et al. [58] | 142 | 15 | 0 | 299 | 15 | 233 | 14 | 1 | 480 | 16 | 0.13 | 0.032 |
Fassbender et al. [34] | 34 | 31 | 10 | 99 | 51 | 19 | 20 | 18 | 58 | 56 | 0.02 | 0.491 |
Gyorffy et al. [35] | 46 | 34 | 27 | 126 | 88 | 42 | 27 | 34 | 111 | 95 | < 0.001 | 0.461 |
Skrabic et al. [59] | 54 | 55 | 25 | 163 | 105 | 48 | 72 | 12 | 168 | 96 | 0.04 | 0.363 |
Bianco et al. [60] | 10 | 18 | 3 | 38 | 24 | 11 | 20 | 5 | 42 | 30 | 0.39 | 0.416 |
San Pedro et al. [38] | 24 | 36 | 11 | 84 | 58 | 31 | 43 | 14 | 105 | 71 | 0.88 | 0.403 |
Garcia et al. [61] | 115 | 79 | 22 | 309 | 123 | 121 | 69 | 13 | 311 | 95 | 0.46 | 0.233 |
Lemos et al. [41] | 70 | 94 | 41 | 234 | 176 | 91 | 95 | 46 | 277 | 187 | 0.02 | 0.403 |
Israni et al. [42] | 91 | 112 | 33 | 294 | 178 | 80 | 98 | 19 | 258 | 136 | 0.15 | 0.345 |
Panierakis et al. [15] | 34 | 59 | 7 | 127 | 73 | 10 | 64 | 22 | 84 | 108 | < 0.001 | 0.562 |
Yavuz et al. [44] | 37 | 58 | 22 | 132 | 102 | 41 | 66 | 27 | 148 | 120 | 0.96 | 0.447 |
Bonakdaran et al. [46] | 34 | 28 | 7 | 96 | 42 | 20 | 17 | 8 | 57 | 33 | 0.21 | 0.366 |
Mohammadnejad et al. [48] | 32 | 52 | 3 | 116 | 58 | 59 | 41 | 0 | 159 | 41 | < 0.001 | 0.205 |
Greer et al. [50] | 18 | 26 | 6 | 62 | 38 | 26 | 24 | 5 | 76 | 34 | 0.87 | 0.309 |
Abd-Allah et al. [52] | 42 | 66 | 12 | 150 | 90 | 33 | 69 | 18 | 135 | 105 | 0.06 | 0.437 |
Cheon et al. [62] | 66 | 15 | 0 | 147 | 15 | 105 | 8 | 0 | 218 | 8 | 0.69 | 0.035 |
Khalid et al. [63] | 63 | 22 | 15 | 148 | 52 | 19 | 16 | 15 | 54 | 46 | 0.01 | 0.46 |
Iyer et al. [64] | 19 | 14 | 17 | 52 | 48 | 16 | 16 | 18 | 48 | 52 | 0.01 | 0.52 |
Rasoul et al. [57] | 96 | 96 | 61 | 288 | 218 | 156 | 36 | 22 | 348 | 80 | < 0.001 | 0.186 |
Ahmed et al. [65] | 0 | 42 | 8 | 42 | 58 | 0 | 40 | 10 | 40 | 60 | < 0.001 | 0.6 |
Study author | T1DM cases | Healthy control | P-HWE | MAF | ||||||||
BB | Bb | bb | B | b | BB | Bb | bb | B | b | |||
BsmI (rs1544410) | ||||||||||||
Hauache et al. [66] | 13 | 39 | 26 | 65 | 91 | 12 | 43 | 39 | 67 | 121 | 0.97 | 0.643 |
Chang et al. [58] | 4 | 16 | 137 | 24 | 290 | 1 | 16 | 231 | 18 | 478 | 0.22 | 0.963 |
Fassbender et al. [34] | 14 | 35 | 26 | 63 | 87 | 18 | 25 | 14 | 61 | 53 | 0.37 | 0.464 |
Gyorffy et al. [35] | 19 | 46 | 42 | 84 | 130 | 16 | 53 | 34 | 85 | 121 | 0.53 | 0.587 |
Motohashi et al. [67] | 12 | 64 | 127 | 88 | 318 | 1 | 49 | 172 | 51 | 393 | 0.2 | 0.885 |
Skrabic et al. [59] | 24 | 58 | 52 | 106 | 162 | 17 | 74 | 41 | 108 | 156 | 0.06 | 0.59 |
Turpeinen (Turku) et al. [36] | 97 | 97 | 26 | 291 | 149 | 354 | 388 | 102 | 1096 | 592 | 0.78 | 0.35 |
Turpeinen (Tampere) et al. [36] | 29 | 22 | 7 | 80 | 36 | 533 | 488 | 154 | 1554 | 796 | 0.01 | 0.338 |
Turpeinen (Oulu) et al. [36] | 90 | 103 | 33 | 283 | 169 | 403 | 305 | 110 | 1111 | 525 | < 0.001 | 0.32 |
Audi (barcellona) et al. [37] | 21 | 73 | 59 | 115 | 191 | 46 | 147 | 81 | 239 | 309 | 0.13 | 0.563 |
Audi (navarra) et al. [37] | 20 | 43 | 26 | 83 | 95 | 19 | 53 | 44 | 91 | 141 | 0.65 | 0.607 |
Bianco et al. [60] | 13 | 14 | 4 | 40 | 22 | 14 | 17 | 5 | 45 | 27 | 0.96 | 0.375 |
San Pedro et al. [38] | 15 | 40 | 16 | 70 | 72 | 17 | 44 | 27 | 78 | 98 | 0.9 | 0.556 |
Capoluongo et al. [40] | 62 | 125 | 59 | 249 | 243 | 61 | 122 | 63 | 244 | 248 | 0.89 | 0.504 |
Garcia et al. [61] | 21 | 110 | 77 | 152 | 264 | 14 | 74 | 115 | 102 | 304 | 0.65 | 0.748 |
Lemos et al. [41] | 43 | 96 | 68 | 182 | 232 | 56 | 107 | 85 | 219 | 277 | 0.04 | 0.558 |
Shimada et al. [68] | 32 | 165 | 577 | 229 | 1319 | 7 | 121 | 471 | 135 | 1063 | 0.8 | 0.887 |
Israni et al. [42] | 79 | 120 | 37 | 278 | 194 | 56 | 94 | 47 | 206 | 188 | 0.53 | 0.477 |
Mory et al. [43] | 60 | 57 | 60 | 177 | 177 | 38 | 74 | 70 | 150 | 214 | 0.62 | 0.587 |
Panierakis et al. [15] | 23 | 57 | 20 | 103 | 97 | 38 | 43 | 15 | 119 | 73 | 0.62 | 0.38 |
Yavuz et al. [44] | 20 | 57 | 40 | 97 | 137 | 14 | 59 | 61 | 87 | 181 | 0.96 | 0.675 |
Tawfeek et al. [69] | 3 | 18 | 9 | 24 | 36 | 1 | 8 | 5 | 10 | 18 | 0.36 | 0.642 |
Bonakdaran et al. [46] | 14 | 26 | 29 | 54 | 84 | 16 | 11 | 18 | 43 | 47 | < 0.001 | 0.522 |
Vedralova et al. [49] | 43 | 47 | 14 | 133 | 75 | 30 | 33 | 20 | 93 | 73 | 0.07 | 0.439 |
Mohammadnejad et al. [48] | 11 | 36 | 40 | 58 | 116 | 9 | 45 | 46 | 63 | 137 | 0.66 | 0.685 |
Moubarak et al. [70] | 7 | 25 | 23 | 39 | 71 | 14 | 26 | 10 | 54 | 46 | 0.74 | 0.46 |
Abd-Allah et al. [52] | 27 | 68 | 25 | 122 | 118 | 48 | 52 | 20 | 148 | 92 | 0.36 | 0.383 |
Kafoury et al. [53] | 8 | 13 | 39 | 29 | 91 | 4 | 11 | 41 | 19 | 93 | 0.02 | 0.83 |
Cheon et al. [62] | 0 | 13 | 68 | 13 | 149 | 1 | 4 | 108 | 6 | 220 | < 0.001 | 0.973 |
Khalid et al. [63] | 51 | 32 | 17 | 134 | 66 | 19 | 21 | 10 | 59 | 41 | 0.35 | 0.41 |
Iyer et al. [64] | 8 | 12 | 30 | 28 | 72 | 26 | 12 | 12 | 64 | 36 | < 0.001 | 0.36 |
Ali et al. [56] | 30 | 45 | 25 | 105 | 95 | 62 | 28 | 12 | 152 | 52 | 0.005 | 0.254 |
Rasoul et al. [57] | 141 | 83 | 29 | 365 | 141 | 120 | 66 | 28 | 306 | 122 | < 0.001 | 0.285 |
Ahmed et al. [65] | 8 | 35 | 7 | 51 | 49 | 32 | 18 | 0 | 82 | 18 | < 0.001 | 0.19 |
Study author | T1DM cases | Healthy control | P-HWE | MAF | ||||||||
AA | Aa | aa | A | a | AA | Aa | aa | A | a | |||
ApaI (rs7975232) | ||||||||||||
Chang et al. [58] | 16 | 76 | 65 | 108 | 206 | 13 | 105 | 130 | 131 | 365 | 0.16 | 0.735 |
Gyorffy et al. [35] | 23 | 27 | 57 | 73 | 141 | 33 | 45 | 25 | 111 | 95 | 0.21 | 0.461 |
Skrabic et al. [59] | 66 | 52 | 16 | 184 | 84 | 51 | 66 | 15 | 168 | 96 | 0.35 | 0.363 |
Turpeinen (Turku) et al. [36] | 35 | 106 | 57 | 176 | 220 | 152 | 441 | 204 | 745 | 849 | 0.001 | 0.532 |
Turpeinen (Tampere) et al. [36] | 13 | 23 | 20 | 49 | 63 | 69 | 229 | 152 | 367 | 533 | 0.25 | 0.592 |
Turpeinen (Oulu) et al. [36] | 43 | 115 | 81 | 201 | 277 | 165 | 389 | 289 | 719 | 967 | 0.09 | 0.573 |
Bianco et al. [60] | 18 | 11 | 2 | 47 | 15 | 11 | 20 | 5 | 42 | 30 | 0.39 | 0.416 |
San Pedro et al. [38] | 15 | 37 | 19 | 67 | 75 | 28 | 43 | 17 | 99 | 77 | 0.94 | 0.437 |
Garcia et al. [61] | 54 | 115 | 44 | 223 | 203 | 43 | 125 | 35 | 211 | 195 | < 0.001 | 0.48 |
Lemos et al. [41] | 55 | 100 | 50 | 210 | 200 | 68 | 101 | 63 | 237 | 227 | 0.04 | 0.489 |
Israni et al. [42] | 85 | 133 | 18 | 303 | 169 | 60 | 110 | 27 | 230 | 164 | 0.03 | 0.416 |
Panierakis et al. [15] | 37 | 57 | 6 | 131 | 69 | 23 | 58 | 15 | 104 | 88 | 0.03 | 0.458 |
Yavuz et al. [44] | 36 | 58 | 23 | 130 | 104 | 35 | 70 | 31 | 140 | 132 | 0.72 | 0.485 |
Bonakdaran et al. [46] | 13 | 52 | 4 | 78 | 60 | 18 | 26 | 1 | 62 | 28 | 0.01 | 0.311 |
Mohammadnejad et al. [48] | 27 | 48 | 12 | 102 | 72 | 27 | 57 | 16 | 111 | 89 | 0.12 | 0.445 |
Greer et al. [50] | 15 | 24 | 11 | 54 | 46 | 12 | 32 | 11 | 56 | 54 | 0.22 | 0.49 |
Abd-Allah et al. [52] | 44 | 65 | 11 | 153 | 87 | 36 | 68 | 16 | 140 | 100 | 0.06 | 0.416 |
Cheon et al. [62] | 5 | 32 | 44 | 42 | 120 | 9 | 34 | 70 | 52 | 174 | 0.1 | 0.769 |
Khalid et al. [63] | 49 | 44 | 7 | 142 | 58 | 26 | 21 | 3 | 73 | 27 | 0.64 | 0.27 |
Nasreen et al. [54] | 14 | 25 | 5 | 53 | 35 | 15 | 25 | 4 | 55 | 33 | 0.15 | 0.375 |
Iyer et al. [64] | 17 | 16 | 17 | 50 | 50 | 18 | 16 | 16 | 52 | 48 | 0.01 | 0.48 |
Mukhtar et al. [55] | 43 | 26 | 33 | 112 | 92 | 86 | 0 | 14 | 172 | 28 | < 0.001 | 0.14 |
Rasoul et al. [57] | 192 | 31 | 29 | 415 | 89 | 162 | 37 | 15 | 361 | 67 | < 0.001 | 0.156 |
Ahmed et al. [65] | 24 | 22 | 4 | 70 | 30 | 37 | 13 | 0 | 87 | 13 | < 0.001 | 0.15 |
P-HWE P value for Hardy–Weinberg equilibrium, MAF minor allele frequency of control group